Deltex Medical Group plc
DTXMF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $4,544 | $1,208 | $4,534 | $12,872 |
| - Cash | $242 | $705 | $471 | $413 |
| + Debt | $2,011 | $1,921 | $2,004 | $1,730 |
| Enterprise Value | $6,313 | $2,424 | $6,067 | $14,189 |
| Revenue | $2,056 | $1,776 | $2,482 | $2,259 |
| % Growth | 15.8% | -28.4% | 9.9% | – |
| Gross Profit | $1,398 | $1,125 | $1,839 | $1,575 |
| % Margin | 68% | 63.3% | 74.1% | 69.7% |
| EBITDA | -$807 | -$919 | -$819 | -$691 |
| % Margin | -39.3% | -51.7% | -33% | -30.6% |
| Net Income | -$1,797 | -$1,282 | -$1,145 | -$966 |
| % Margin | -87.4% | -72.2% | -46.1% | -42.8% |
| EPS Diluted | -0.001 | -0.001 | -0.002 | -0.002 |
| % Growth | 18.2% | 35.3% | 0% | – |
| Operating Cash Flow | -$481 | -$1,195 | -$606 | -$291 |
| Capital Expenditures | -$9 | -$370 | -$744 | -$644 |
| Free Cash Flow | -$490 | -$1,565 | -$1,350 | -$935 |